Side Effects of fosfomycin: A Synthesis of Findings from 29 Studies
- Home
- Side Effects of fosfomycin
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of fosfomycin: A Synthesis of Findings from 29 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Fosfomycin is gaining attention as a potential treatment option for infections caused by methicillin-resistant Staphylococcus aureus (MRSA). 25 found that the combination of fosfomycin and imipenem was effective in treating MRSA infective endocarditis and complicated bacteremia. Additionally, 26 reported that combining fosfomycin and teicoplanin was effective against vertebral osteomyelitis caused by vancomycin-tolerant MRSA. 19 suggested that oral fosfomycin-trometamol could be a viable treatment option for catheter-associated urinary tract infections (CAUTIs). However, 15 indicated that fosfomycin might lead to acidosis and sodium overload in pregnant women in Indonesia, potentially affecting the health of newborns.
Reasons for Side Effects
The side effects of fosfomycin could arise from how the drug is metabolized in the body or how it interacts with the target bacterial cells. Fosfomycin works by inhibiting the synthesis of bacterial cell walls, inhibiting bacterial growth. This mechanism of action differs from other antibiotics, which can lead to unique side effects associated with fosfomycin.
Common Side Effects
Diarrhea
Fosfomycin can disrupt the balance of gut microbiota, potentially leading to diarrhea. 26 and 15 reported cases of diarrhea in their studies.
Hypernatremia
Fosfomycin may increase sodium levels in the body. 11 observed an increase in sodium levels in neonates after fosfomycin administration. 9 found that hypernatremia occurred in 33.33% of critically ill patients.
Hypokalemia
Fosfomycin may decrease potassium levels in the body. 9 reported a 28.57% incidence of hypokalemia among critically ill patients.
Pseudomembranous Colitis
6 documented a case of pseudomembranous colitis following fosfomycin treatment.
Liver Dysfunction
6 reported cases of liver dysfunction after fosfomycin administration.
Skin Disorders
6 documented cases of skin disorders after fosfomycin treatment.
Side Effects Management
Diarrhea
If diarrhea occurs, ensure adequate hydration and consult a physician. If necessary, antidiarrheal medications may be prescribed.
Hypernatremia
Seek medical attention according to the doctor's instructions if hypernatremia occurs.
Hypokalemia
Seek medical attention according to the doctor's instructions if hypokalemia occurs.
Pseudomembranous Colitis
If pseudomembranous colitis is suspected, consult a doctor immediately. Appropriate treatment is necessary.
Liver Dysfunction
If liver dysfunction is suspected, consult a doctor immediately. Appropriate treatment is necessary.
Skin Disorders
Consult a doctor if skin disorders develop.
Comparison Across Studies
Commonalities
Many studies have shown that fosfomycin is effective against multidrug-resistant bacteria, including MRSA.
Differences
The incidence and types of side effects can vary depending on the administration method, the drugs used in combination, and the patient population studied. It is crucial to interpret the findings of each study carefully.
Caution in Real-Life Application
While fosfomycin holds promise as an effective option for combating multidrug-resistant bacteria, it's essential to consider the risk of side effects. Particular caution is required for pregnant women, newborns, and patients with impaired kidney or liver function. It is crucial to follow the doctor's instructions and carefully monitor for any side effects when using fosfomycin.
Current Research Limitations
There is still insufficient research on fosfomycin. Data on long-term side effects and safety are limited. Research on combination therapies involving fosfomycin is also scarce.
Future Research Directions
Further studies are needed on the long-term side effects and safety of fosfomycin, combination therapies involving fosfomycin, and new indications for its use. These studies could help ensure the safe and effective use of fosfomycin.
Conclusion
Fosfomycin shows potential as a viable option for treating infections caused by multidrug-resistant bacteria, but it is crucial to be aware of the risk of side effects. Always follow your doctor's instructions and carefully monitor for any side effects when using fosfomycin. With ongoing research, we can expect to see the safe and effective use of fosfomycin expand in the future.
Benefit Keywords
Risk Keywords
Article Type
Author: JonesL M, SpectorS L, EnglishG M, Taylor-DawsonK
Language : English
Author: SahayJ N, ChatterjeeS S, EnglerC
Language : English
Author: SarsfieldJ K, ThomsonG E
Language : English
Author: PipkornU, GeterudA
Language : English
Author: ClaytonD E, KooistraJ B, GellerM, OuelletteJ, CohenM, ReedC E, BusseW
Language : English
Author: MayamaT, YokotaM, ShimataniI, OhyagiH
Language : English
Author: ClaesJ, Van de HeyningP H, CretenW, Van HoofM
Language : English
Author: MatusikElodie, DemanetJulien, AlvesIsabelle, ToneAlina, EttaharNicolas, LemtiriJustine, PoteyCamille, GautierSophie, LambiotteFabien, GaboriauLouise
Language : English
Author: ChenTzu-Ting, ChangYun-Fu, WuYea-Chwen
Language : English
Author: AnastasiaAntonio, BonuraSilvia, RubinoRaffaella, GiammancoGiovanni Maurizio, MiccichèIrene, Di PaceMaria Rita, ColombaClaudia, CascioAntonio
Language : English
Author: ObieroChristina W, WilliamsPhoebe, MurungaSheila, ThitiriJohnstone, OmolloRaymond, WalkerAnn Sarah, EgondiThaddaeus, NyaokeBorna, CorreiaErika, KaneZoe, GastineSilke, KipperKarin, StandingJoseph F, EllisSally, SharlandMike, BerkleyJames Alexander,
Language : English
Author: NishikawaYuriko, SatoNobuhiro, TsukinagaShintaro, UchiyamaKan, KoidoShigeo, IshikawaDai, OhkusaToshifumi
Language : English
Author: YildizIlknur Esen, TopcuAtilla, BahceciIlkay, ArpaMedeni, TumkayaLevent, MercantepeTolga, BatcikSule, YildizYasin
Language : English
Author: PorrecaAngelo, D'AgostinoDaniele, RomagnoliDaniele, Del GiudiceFrancesco, MaggiMartina, PalmerKatie, FalabellaRoberto, De BerardinisEttore, SciarraAlessandro, FerroMatteo, ArtibaniWalter, MironeVincenzo, BusettoGian Maria
Language : English
Author: RosanaYeva, OcviyantiDwiana, HalimMelissa, HarlindaFriza Yossy, AmranRahmah, AkbarWafridha, BillyMatthew, AkhmadSyadza Rhizky Putri
Language : English
Author: CaiTommaso, TamaniniIrene, MatteviDaniele, VerzePaolo, PalmieriAlessandro, MalossiniGianni, MironeVincenzo, NovelliAndrea, TasciniCarlo, JohansenTruls E Bjerklund
Language : English
Author: AboyanI A, OrlovYu N, VoloshinaO A, OrlovN V, PavlovD S
Language : Russian
Author: BradleyMegan S, BeigiRichard H, ShepherdJonathan P
Language : English
Author: CaiTommaso, CocciAndrea, VerzePaolo, RizzoMichele, PalmieriAlessandro, LiguoriGiovanni, TrombettaCarlo, AdembriChiara, CariniMarco, BartolettiRiccardo, WagenlehnerFlorian M, BonkatGernot, MironeVincenzo, Bjerklund JohansenTruls E, NovelliAndrea
Language : English
Author: de JongLoek A W, van der LindenPaul D, RoukensMonique M B, van de GardeEwoudt M W, van der VeldenAlike W, NatschStephanie,
Language : English
Author: Perdigão NetoLauro Vieira, OliveiraMaura S, MartinsRoberta Cristina Ruedas, MarchiAna Paula, GauderetoJuliana Januário, da CostaLucianna Auxi Teixeira Josino, de LimaLia Fernandes Alves, TakedaChristianne Fernandes Valente, CostaSilvia F, LevinAnna S
Language : English
Author: Coronado-ÁlvarezNieves M, ParraDiego, Parra-RuizJorge
Language : English
Author: RobertsMatthew J, ScottSusan, HarrisPatrick N, NaberKurt, WagenlehnerFlorian M E, DoiSuhail A R
Language : English
Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.
Author: Los-ArcosIbai, PigrauCarles, Rodríguez-PardoDolors, Fernández-HidalgoNuria, AndreuAntonia, LarrosaNieves, AlmiranteBenito
Language : English
Author: del RíoAna, GaschOriol, MorenoAsunción, PeñaCarmen, CuquetJordi, SoyDolors, MestresCarlos A, SuárezCristina, PareJuan C, TubauFe, Garcia de la MàriaCristina, MarcoFrancesc, CarratalàJordi, GatellJosé M, GudiolFrancisco, MiróJosé M,
Language : English
Author: LeeWen-Sen, ChenYen-Chuo, ChenHung-Ping, ChenTso-Hsiao, ChengChung-Yi
Language : English
Author: CourjonJ, PulciniC, CuaE, RissoK, GuillouetF, BernardE, RogerP-M
Language : English
Author: WagenlehnerFlorian M E, HoymeUdo, KaaseMartin, FünfstückReinhard, NaberKurt G, SchmiemannGuido
Language : English
Author: WagenlehnerF M E, SchmiemannG, HoymeU, FünfstückR, Hummers-PradierE, KaaseM, KniehlE, SelbachI, SesterU, VahlensieckW, WatermannD, NaberK G
Language : German
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.